Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
For a free, no-obligation consultation to discuss your situation and learn more about your legal options, call our office today at (304) 346-2889 or contact us through our online form.
Overall, discontinuation rates due to adverse events were low, with 5.9% for CagriSema versus 3.5% for placebo in REDEFINE 1 and 8.4% with CagriSema versus 3% with placebo in REDEFINE 2
This partial reversal may be driven by factors such as compliance challenges, waning drug efficacy, or measurement limitations
If you experience mild side effects, monitor them closely and consult your healthcare provider
Entails keeping up with new behavior habits to continue or maintain weight loss long term
Some patients are happy with their progress but still want help with: That does not necessarily mean GLP-1 treatment failed
